Explore more price target data and ratings for Baxter International Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Baxter International Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc…
Baxter International reported second-quarter 2026 results showing revenue growth and higher earnings versus the year-ago quarter, supported by volume gains in Infusion Therapies and Advanced Surgery.Financial Highlights¹ Reported as “Net sales”. ² Reported as “Net income (loss) attributable to Baxt…
Net sales grew 5% year-over-year in Q2 2026, with net income rising to $126 million, driven by strong segment performance and cost controls, despite ongoing macroeconomic and regulatory challenges. Special items and restructuring costs continued to impact results.Original document: Baxter Internati…
What Happened? Shares of healthcare company Baxter International NYSE:BAXjumped 8.7% in the afternoon session after the company reported second-quarter results that beat analyst expectations on the top and bottom lines and raised its full-year financial forecast.The company announced revenue of $2…
Second quarter results exceeded expectations with 5% organic revenue growth and strong free cash flow. Adjusted EPS guidance was raised due to a one-time tariff refund, while ongoing supply and macroeconomic risks are being closely monitored.Based on Baxter International Inc. [BAX] Q2 2026 Audio Tr…
Second quarter sales grew 5% year-over-year to $3 billion, with broad-based segment growth and strong performance in Advanced Surgery and drug compounding. Adjusted EPS was $0.56, aided by a one-time $75 million tariff refund. Full-year guidance was raised for both sales and EPS, with continued foc…
Second-quarter 2026 results surpassed expectations with 5% sales growth and strong free cash flow. Full-year guidance was raised, with adjusted EPS now projected at $1.95–$2.15 and a focus on debt reduction and operational improvement.Original document: Baxter International Inc. [BAX] Slides Releas…
Healthcare company Baxter International NYSE:BAXwill be reporting results this Thursday before market open. Here’s what you need to know.Baxter beat analysts’ revenue expectations last quarter, reporting revenues of $2.70 billion, up 2.9% year on year. It was a very strong quarter for the company…
(15:50 GMT) Baxter International Price Target Raised to $24.00/Share From $22.00 by Evercore ISI Group
